An Extension Study of Onartuzumab in Participants With Solid Tumors on Study Treatment Previously Enrolled in a Company Sponsored Study
Clinical trial NCT02488330 · COMPLETED
Trial details
- NCT number
- NCT02488330
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-27
- Primary completion
- 2018-06-29
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.